|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bieri U, Moch H, Dehler S, Korol D and
Rohrmann S: Changes in autopsy rates among cancer patients and
their impact on cancer statistics from a public health point of
view: A longitudinal study from 1980 to 2010 with data from Cancer
Registry Zurich. Virchows Arch. 466:637–643. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of disease study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yonemura Y, Endou Y, Sasaki T, Hirano M,
Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M and Li Y:
Surgical treatment for peritoneal carcinomatosis from gastric
cancer. Eur J Surg Oncol. 36:1131–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coccolini F, Gheza F, Lotti M, Virzì S,
Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L
and Catena F: Peritoneal carcinomatosis. World J Gastroenterol.
19:6979–6994. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yonemura Y, Kawamura T, Bandou E,
Tsukiyama G, Endou Y and Miura M: The natural history of free
cancer cells in the peritoneal cavity. Recent Results Cancer Res.
169:11–23. 2007.PubMed/NCBI
|
|
7
|
Klaver YL, Lemmens VE, Creemers GJ, Rutten
HJ, Nienhuijs SW and de Hingh IH: Population-based survival of
patients with peritoneal carcinomatosis from colorectal origin in
the era of increasing use of palliative chemotherapy. Ann Oncol.
22:2250–2256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sugarbaker PH and Ryan DP: Cytoreductive
surgery plus hyperthermic perioperative chemotherapy to treat
peritoneal metastases from colorectal cancer: Standard of care or
an experimental approach? Lancet Oncol. 13:e362–e369. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blackham AU, Swett K, Eng C, Sirintrapun
J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P and
Levine EA: Perioperative systemic chemotherapy for appendiceal
mucinous carcinoma peritonei treated with cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy. J Surg Oncol.
109:740–745. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McConnell YJ, Mack LA, Gui X, Carr NJ,
Sideris L, Temple WJ, Dubé P, Chandrakumaran K, Moran BJ and Cecil
TD: Cytoreductive surgery with hyperthermic intraperitoneal
chemotherapy: An emerging treatment option for advanced goblet cell
tumors of the appendix. Ann Surg Oncol. 21:1975–1982. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Graziosi L, Cantarella F, Mingrone E,
Gunnellini M, Cavazzoni E, Liberati M and Donini A: Preliminary
results of prophylactic HIPEC in patients with locally advanced
gastric cancer. Ann Ital Chir. 84:551–556. 2013.PubMed/NCBI
|
|
12
|
Mallory M, Gogineni E, Jones GC, Greer L
and Simone CB II: Therapeutic hyperthermia: The old, the new, and
the upcoming. Crit Rev Oncol Hematol. 97:56–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kepenekian V, Aloy MT, Magné N, Passot G,
Armandy E, Decullier E, Sayag-Beaujard A, Gilly FN, Glehen O and
Rodriguez-Lafrasse C: Impact of hyperthermic intraperitoneal
chemotherapy on Hsp27 protein expression in serum of patients with
peritoneal carcinomatosis. Cell Stress Chaperones. 18:623–630.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lianos GD, Alexiou GA, Mangano A, Mangano
A, Rausei S, Boni L, Dionigi G and Roukos DH: The role of heat
shock proteins in cancer. Cancer Lett. 360:114–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ischia J and So AI: The role of heat shock
proteins in bladder cancer. Nat Rev Urol. 10:386–395. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zorzi E and Bonvini P: Inducible hsp70 in
the regulation of cancer cell survival: Analysis of chaperone
induction, expression and activity. Cancers (Basel). 3:3921–3956.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Chen M, Zhou J and Zhang X: HSP27,
70 and 90, anti-apoptotic proteins, in clinical cancer therapy
(Review). Int J Oncol. 45:18–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schilling D, Bayer C, Li W, Molls M,
Vaupel P and Multhoff G: Radiosensitization of normoxic and hypoxic
h1339 lung tumor cells by heat shock protein 90 inhibition is
independent of hypoxia inducible factor-1α. PLoS One. 7:e311102012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sugarbaker PH: Cytoreductive surgery and
perioperative intraperitoneal chemotherapy as a curative approach
to pseudomyxoma peritonei syndrome. Tumori. 87:S3–S5. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang C, Hua J, Li J, Zhen J, Wang F, Zhao
Q, Shuang J and Du J: Comparison of long-term results between
laparoscopy-assisted gastrectomy and open gastrectomy with D2
lymphadenectomy for advanced gastric cancer. Am J Surg.
208:391–396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kow AW, Kwon CH, Song S, Shin M, Kim JM
and Joh JW: Risk factors of peritoneal recurrence and outcome of
resected peritoneal recurrence after liver resection in
hepatocellular carcinoma: Review of 1222 cases of hepatectomy in a
tertiary institution. Ann Surg Oncol. 19:2246–2255. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rodriguez EF, Monaco SE, Khalbuss W,
Austin RM and Pantanowitz L: Abdominopelvic washings: A
comprehensive review. Cytojournal. 10:72013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Königsrainer I, Horvath P, Struller F,
Forkl V, Königsrainer A and Beckert S: Risk factors for recurrence
following complete cytoreductive surgery and HIPEC in colorectal
cancer-derived peritoneal surface malignancies. Langenbecks Arch
Surg. 398:745–749. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cashin PH, Graf W, Nygren P and Mahteme H:
Cytoreductive surgery and intraperitoneal chemotherapy for
colorectal peritoneal carcinomatosis: Prognosis and treatment of
recurrences in a cohort study. Eur J Surg Oncol. 38:509–515. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sevin M, Girodon F, Garrido C and de
Thonel A: HSP90 and HSP70: Implication in inflammation processes
and therapeutic approaches for myeloproliferative neoplasms.
Mediators Inflamm. 2015:9702422015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jego G, Hazoumé A, Seigneuric R and
Garrido C: Targeting heat shock proteins in cancer. Cancer Lett.
332:275–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sherman MY and Gabai VL: Hsp70 in cancer:
Back to the future. Oncogene. 34:4153–4161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cui XB, Yu ZY, Wang W, Zheng YQ, Liu W and
Li LX: Co-inhibition of HSP70/HSP90 synergistically sensitizes
nasopharyngeal carcinoma cells to thermotherapy. Integr Cancer
Ther. 11:61–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyagawa T, Saito H, Minamiya Y, Mitobe K,
Takashima S, Takahashi N, Ito A, Imai K, Motoyama S and Ogawa J:
Inhibition of Hsp90 and 70 sensitizes melanoma cells to
hyperthermia using ferromagnetic particles with a low Curie
temperature. Int J Clin Oncol. 19:722–730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pelz JO, Vetterlein M, Grimmig T, Kerscher
AG, Moll E, Lazariotou M, Matthes N, Faber M, Germer CT,
Waaga-Gasser AM and Gasser M: Hyperthermic intraperitoneal
chemotherapy in patients with peritoneal carcinomatosis: Role of
heat shock proteins and dissecting effects of hyperthermia. Ann
Surg Oncol. 20:1105–1113. 2013. View Article : Google Scholar : PubMed/NCBI
|
